Solaris Resources to Get C$130 Million Investment from Zijin Mining
By Robb M. Stewart
Solaris Resources has lined up a 130 million Canadian dollar ($97.1 million) investment from China's Zijin Mining that will help fund development of the Canadian exploration company's flagship Warintza project in southeastern Ecuador.
Solaris said Thursday the gold-focused mining giant will invest through an affiliate by way of a private placement of shares. Solaris plans to issue almost 28.5 million shares at C$4.55 each, a premium of 14% to the previous day's closing price.
When the placement closes, Zijin will own a roughly 15% stake in Solaris.
Solaris said in addition to advancing the Warintza project, it also will use the proceeds for working capital and general corporate purposes.
With the investment, Zijin will have the right to nominate a member to Solaris's board while it control and at least 5% stake in the Canadian company. The agreement also entitles Zijin participation rights to buy additional securities to maintain a proportional interest in the company.
Solaris, which is developing a portfolio of copper and gold assets in the Americas, earlier this week said it planed to add a stock listing on the NYSE American stock exchange in the first half of the year to meet a demand from U.S. investors. The company is nearing the completion of its second phase of mineral resource drilling at Warintza, which is expected to boost the mineral resource estimate for the project.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
January 11, 2024 07:19 ET (12:19 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth